Zhongnan Medical Journal Press

Home Results

A total of 2195 result was found. Results

Expression of ANKRD22 and its effects on pancreatic cancer

Published on New Medicine 2025,35(7):819-826.
7922 times 1074 times

SUN Zhijia SONG Zhuo LIU Xu LI Xinji WANG Yingjie

Pancreatic cancer ANKRD22 Clinical prognosis Cell proliferation Cell invasion
Details
WTAP promotes lipopolysaccharides-induced ferroptosis in human renal tubular epithelial cells by regulating ACSL4 m6A methylation

Published on New Medicine 2025,35(7):827-835.
9744 times 1071 times

ZHANG Qin TANG Qing CHEN Bingyang

Wilms' tumor 1-associating protein Long chain acyl-CoA synthetase 4 N6-methyladenosine Ferroptosis Sepsis
Details
The role of zinc homeostasis in prostate diseases and potential mechanisms

Published on New Medicine 2025,35(7):846-854.
10087 times 1234 times

HAN Yutong FAN Jiuming WANG Tiankun QI Zihao ZHANG Yuanyuan HOU Junqing

Zinc Zinc Homeostasis Prostatic diseases Prostate cancer Benign prostatic hyperplasia
Details
Application of the case-based learning combined with the BOPPPS teaching method in standardized training of orthopedic resident physicians

Published on New Medicine 2025,35(7):855-860.
7767 times 1056 times

LIAO Bo ZHANG Xiaoping ZHAO Hai'en YAN Kang ZHAO Jian DONG Xin

BOPPPS teaching method Case-based learning Department of orthopedics Standardized training of residents Practical ability
Details
Guide on Methodological Standards in Pharmacoepidemiology in China (2nd edition) and their series interpretation (7): selection of control groups

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):725-733.
9096 times 1446 times

TIAN Qinxi ZHAN Siyan SUN Feng YANG Zhirong

Pharmacoepidemiology Methodology Guidelines Control Interventional research Non-interventional research
Details
Evaluation of the efficacy and safety of dapagliflozin and empagliflozin in the treatment of patients with diabetic nephropathy based on real-world data

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):734-742.
11230 times 1440 times

HU Ruiwen JI Cheng LI Li

Diabetic nephropathy Dapagliflozin Empagliflozin Real world study Efficacy Safety
Details
Development and application of a rapid identification algorithm for cutaneous lupus erythematosus and its subtypes based on medical insurance databases

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):743-752.
7482 times 1101 times

WANG Yutong MENG Xianglong PAN Yu WEI Chen JIN Hui WANG Shengfeng

Cutaneous lupus erythematosus Medical insurance Rapid identification algorithm
Details
Safety of budesonide inhalation aerosol for chronic obstructive pulmonary disease: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):771-784.
8243 times 1217 times

QIN Honghua GUO Haiyan LI Haifeng TONG Xiaona WANG Ying

Budesonide Chronic obstructive pulmonary disease Adverse drug reaction Meta-analysis Randomized controlled trial
Details
Efficacy and safety of tislelizumab combined with anlotinib in the treatment of advanced non-small cell lung cancer: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):785-794.
8418 times 1166 times

TENG Xinli LIU Bin XIU Junli ZHOU Xiaohong

Tislelizumab Anlotinib Non-small cell lung cancer Meta-analysis Systematic review
Details
Efficacy and safety of dose-optimization strategies for CDK4/6 inhibitors in HR+/HER2- advanced breast cancer: a Meta-analysis

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):795-805.
7841 times 1037 times

ZHENG Yating LIU Songling ZHOU Liyan

CDK4/6 inhibitor HR+/HER2- breast cancer Dose-optimization Meta-analysis
Details
Sugemalimab as first-line treatment for non-small cell lung cancer: a rapid health technology assessment

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):806-814.
7535 times 1112 times

HOU Yibing KANG Shuo GONG Yuan WANG Xiaohui NIE Ying LIU Huanlong

Sugemalimab Non-small cell lung cancer Effectiveness Safety Economics Rapid health technology assessment
Details
A case report of acute kidney injury caused by semaglutide in combination with multiple medications

Published on Chinese Journal of Pharmacoepidemiology 2025,34(7):835-840.
9204 times 1219 times

GU Jiamei TANG Chenquan JIANG Yi YIN Hao FENG Chen XUE Yi

Semaglutide Metformin Dapagliflozin Sacubitril/Valsartan Acute kidney injury Adverse reactions
Details
A multidimensional perspective on MIMIC database: a review of development history, data overview, analytical methods, and global influence

Published on Journal of Mathematical Medicine 2025,38(7):484-490.
11160 times 1161 times

WANG Xiaoli MAO Zhi

MIMIC database Development history Statistical methods Data quality Bias Global influence
Details
An epidemiological study of overweight and obesity among primary and secondary school students in Baoshan District, Shanghai

Published on Journal of Mathematical Medicine 2025,38(7):491-499.
10204 times 1198 times

MAI Yiyi XIANG Man HUANG Aiyi ZHU Xinya LI Meiyue LI Guangping JI Wei RONG Fen

Primary and secondary school students Overweight Obesity Prevalence
Details
Analysis of secular variation trends of incidence and SARIMA model prediction of other infectious diarrhea in Dali Prefecture from 2005 to 2024

Published on Journal of Mathematical Medicine 2025,38(7):500-507.
9631 times 1151 times

XU Ran MA Yajiao YOU Fengfeng CHEN Ling MA Yi ZHAO Runfang ZHAO Jing Lyu Shisai HE Zuo

Other infectious diarrheal Incidence Trend Joinpoint regression SARIMA model
Details